Media coverage
1
Media coverage
Title A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1) Media name/outlet Pharmacy Choice Country United States Date 1/02/19 Persons Francisco Espinoza